These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 36042446)

  • 1. Protective effects of calcyclin-binding protein against pulmonary vascular remodeling in flow-associated pulmonary arterial hypertension.
    Zhou J; Li F; Yang Y
    Respir Res; 2022 Aug; 23(1):223. PubMed ID: 36042446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CYLD mediates human pulmonary artery smooth muscle cell dysfunction in congenital heart disease-associated pulmonary arterial hypertension.
    Zhou JJ; Li H; Li L; Li Y; Wang PH; Meng XM; He JG
    J Cell Physiol; 2021 Sep; 236(9):6297-6311. PubMed ID: 33507567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing EIF3A ameliorates pulmonary arterial hypertension through HDAC1 and PTEN/PI3K/AKT pathway in vitro and in vivo.
    Yang HT; Wang G; Zhu PC; Xiao ZY
    Exp Cell Res; 2023 May; 426(1):113555. PubMed ID: 36921705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synemin promotes pulmonary artery smooth muscle cell phenotypic switch in shunt-induced pulmonary arterial hypertension.
    Zhou J
    ESC Heart Fail; 2022 Oct; 9(5):3221-3231. PubMed ID: 35769011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasminogen activator Inhibitor-2 inhibits pulmonary arterial smooth muscle cell proliferation in pulmonary arterial hypertension via PI3K/Akt and ERK signaling.
    Zhang S; Wang J; Qi X; Tao X; Xie W; Wan J; Shen YH; Zhai Z
    Exp Cell Res; 2021 Jan; 398(1):112392. PubMed ID: 33227315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A modified Fangji Huangqi decoction ameliorates pulmonary artery hypertension via phosphatidylinositide 3-kinases/protein kinase B-mediated regulation of proliferation and apoptosis of smooth muscle cells in vitro and in vivo.
    Xue Z; Zhou M; Liu Y; Qin H; Li Y; Zhu Y; Yang J
    J Ethnopharmacol; 2023 Oct; 314():116544. PubMed ID: 37088239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Yang Y; Yin L; Zhu M; Song S; Sun C; Han X; Xu Y; Zhao Y; Qi Y; Xu L; Peng JY
    Biomed Pharmacother; 2021 Jan; 133():111056. PubMed ID: 33378960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel roles of YULINK in the migration, proliferation and glycolysis of pulmonary arterial smooth muscle cells: implications for pulmonary arterial hypertension.
    Wu YC; Wang WT; Yang MC; Su YT; Yeh JL; Hsu JH; Wu JR
    Biol Res; 2023 Dec; 56(1):66. PubMed ID: 38057829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgelin exacerbates pulmonary artery smooth muscle cell dysfunction in shunt-related pulmonary arterial hypertension.
    Zhou JJ; Yang J; Li L; Quan RL; Chen XX; Qian YL; Huang L; Wang PH; Li Y; Meng XM; Chen X; Gu Q; He JG
    ESC Heart Fail; 2022 Oct; 9(5):3407-3417. PubMed ID: 35841124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.
    Huang H; Kong L; Luan S; Qi C; Wu F
    Am J Chin Med; 2021; 49(2):437-459. PubMed ID: 33622214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role and mechanism of thrombospondin-4 in pulmonary arterial hypertension associated with congenital heart disease.
    Zeng H; Lan B; Li B; Xie H; Zhao E; Liu X; Xue X; Sun J; Su L; Zhang Y
    Respir Res; 2024 Aug; 25(1):313. PubMed ID: 39154161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA-SMILR modulates RhoA/ROCK signaling by targeting miR-141 to regulate vascular remodeling in pulmonary arterial hypertension.
    Lei S; Peng F; Li ML; Duan WB; Peng CQ; Wu SJ
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H377-H391. PubMed ID: 32559140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension.
    Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W
    Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CacyBP/SIP nuclear translocation regulates p27Kip1 stability in gastric cancer cells.
    Niu YL; Li YJ; Wang JB; Lu YY; Liu ZX; Feng SS; Hu JG; Zhai HH
    World J Gastroenterol; 2016 Apr; 22(15):3992-4001. PubMed ID: 27099442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease.
    Shen Q; Chen W; Liu J; Liang Q
    Life Sci; 2019 Sep; 232():116546. PubMed ID: 31176777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stox1 induced the proliferation and cell cycle arrest in pulmonary artery smooth muscle cells via AKT signaling pathway.
    Xu Y; Sun Z; Wang Q; Wang T; Liu Y; Yu F
    Vascul Pharmacol; 2019 Sep; 120():106568. PubMed ID: 31207359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
    Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
    Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
    Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dacomitinib, a new pan-EGFR inhibitor, is effective in attenuating pulmonary vascular remodeling and pulmonary hypertension.
    Yu X; Zhao X; Zhang J; Li Y; Sheng P; Ma C; Zhang L; Hao X; Zheng X; Xing Y; Qiao H; Qu L; Zhu D
    Eur J Pharmacol; 2019 May; 850():97-108. PubMed ID: 30753867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.